Organigram Global Inc., a leading cannabis company in Canada, announced impressive financial results for its second quarter of fiscal 2025, which ended on March 31, 2025. The company reported a record gross revenue of $102.8 million, marking a 79% increase from $57.4 million in the same period last year. Net revenue also saw a substantial rise, climbing 74% to reach $65.6 million compared to $37.6 million in the previous year.
A notable factor contributing to this growth was the integration of Motif Labs Ltd., which Organigram acquired on December 6, 2024. This acquisition enabled a full quarter of consolidated financials, boosting overall performance. International sales experienced a remarkable surge, increasing 177% to $6.1 million from $2.2 million in the prior year period.
Adjusted gross margin improved to $21.9 million, or 33%, compared to $11.6 million, or 31%, in the same prior year period. Adjusted EBITDA rose to $4.9 million, a significant turnaround from a loss of $1.0 million in the same quarter last year. Organigram’s total cash position stands at approximately $83.4 million, with minimal debt.
The company continues to hold its top market share position in Canada, leading in several categories, including vapes, pre-rolls, milled flower, hash, and pure CBD gummies. Additionally, Organigram is ranked third in both edibles and dried flower sales.
In a strategic move to expand its market presence, Organigram acquired Collective Project Limited, which allows entry into the rapidly growing beverage segments in both the U.S. and Canadian markets. Currently, Collective Project has distribution in ten U.S. states and six Canadian provinces.
Beena Goldenberg, CEO of Organigram, expressed confidence in the company’s future, stating, “Our record revenue this quarter reflects the strength of our brands and our ability to execute across both domestic and international markets.” She highlighted the growth potential in key international markets, particularly Germany, and the company’s new venture into the U.S. hemp-derived beverage space. Goldenberg anticipates continued momentum as Organigram strengthens its leadership in Canada and approaches the seasonally stronger latter half of the year.
Overall, Organigram’s strong financial performance and strategic acquisitions position the company well to capitalize on the expanding cannabis market, both domestically and internationally.
English 
Spanish 
German 
Czech